CEL SCI CORP (CVM)
CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy
CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy
Roblox Kids and Roblox Select Accounts Now Available Worldwide
Abrams Capital Disposes of Shares of SECURE Waste Infrastructure Corp.
TEGNA CEO Patrick Paolini Appoints Kurt Rao Executive Vice President and Chief Technology and Digital Products Officer
Real’s Monthly Agent Survey: Buyers Pull Back Amid Economic Uncertainty, While Sellers Reset Expectations
Perfect Corp. Launches Industry’s Most Comprehensive AI Hair & Beard API Suite, Combining Virtual Try-On with Intelligent Hair Analysis
Yum! Brands, Inc. Enters into Agreements to Sell Pizza Hut for $2.7 Billion
U.S. Bank Wealth Management Appoints Daniel Farley Chief Investment Officer
Pennymac Names AWS as Preferred Cloud Provider, Expanding Strategic Agreement to Deploy Enterprise-Grade AI and Commercialize its Servicing Platform
Digimarc Extends Its Agent-Native Provenance and Verification Platform to the World’s Leading Agentic AI Ecosystems